Tandem Diabetes Care (TNDM) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Tandem Diabetes Care (TNDM) over the last 12 years, with Q4 2024 value amounting to $16.6 million.
- Tandem Diabetes Care's Accumulated Depreciation & Amortization rose 567.61% to $16.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $16.6 million, marking a year-over-year increase of 567.61%. This contributed to the annual value of $16.6 million for FY2024, which is 567.61% up from last year.
- Per Tandem Diabetes Care's latest filing, its Accumulated Depreciation & Amortization stood at $16.6 million for Q4 2024, which was up 567.61% from $15.7 million recorded in Q4 2023.
- In the past 5 years, Tandem Diabetes Care's Accumulated Depreciation & Amortization ranged from a high of $16.6 million in Q4 2024 and a low of $10.5 million during Q4 2020
- Its 5-year average for Accumulated Depreciation & Amortization is $14.2 million, with a median of $14.3 million in 2022.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 7211.79% in 2020, then skyrocketed by 350.31% in 2022.
- Over the past 5 years, Tandem Diabetes Care's Accumulated Depreciation & Amortization (Quarter) stood at $10.5 million in 2020, then skyrocketed by 32.48% to $13.8 million in 2021, then grew by 3.5% to $14.3 million in 2022, then increased by 9.67% to $15.7 million in 2023, then grew by 5.68% to $16.6 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $16.6 million for Q4 2024, versus $15.7 million for Q4 2023 and $14.3 million for Q4 2022.